Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- $250 million financing led by Qatar Investment Authority with significant participation from four of the largest investment management firms in the US - BridgeBio anticipates this raise,...
(RTTNews) - BridgeBio Pharma, Inc. (BBIO), a company focused on genetic diseases and cancers, said on Friday that it has inked a deal with certain...
Mizuho Markets Americas LLC lifted its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,198 shares of the company’s stock after purchasing an additional 4,600 shares during the quarter. Mizuho Markets […]
Mizuho restated their buy rating on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a report released on Monday morning, Benzinga reports. The firm currently has a $60.00 target price on the stock. Several other equities analysts have also recently issued reports on BBIO. BTIG Research raised their price target on BridgeBio Pharma from […]
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average […]